Abstract

BackgroundChronic glucocorticoid excess has been linked to increased atherosclerosis and general cardiovascular risk in humans. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) increases active glucocorticoid levels within tissues by catalyzing the conversion of cortisone to cortisol. Pharmacological inhibition of 11βHSD1 has been shown to reduce atherosclerosis in murine models. However, the cellular and molecular details for this effect have not been elucidated.Methodology/Principal FindingsTo examine the role of 11βHSD1 in atherogenesis, 11βHSD1 knockout mice were created on the pro-atherogenic apoE−/− background. Following 14 weeks of Western diet, aortic cholesterol levels were reduced 50% in 11βHSD1−/−/apoE−/− mice vs. 11βHSD1+/+/apoE−/− mice without changes in plasma cholesterol. Aortic 7-ketocholesterol content was reduced 40% in 11βHSD1−/−/apoE−/− mice vs. control. In the aortic root, plaque size, necrotic core area and macrophage content were reduced ∼30% in 11βHSD1−/−/apoE−/− mice. Bone marrow transplantation from 11βHSD1−/−/apoE−/− mice into apoE−/− recipients reduced plaque area 39–46% in the thoracic aorta. In vivo foam cell formation was evaluated in thioglycollate-elicited peritoneal macrophages from 11βHSD1+/+/apoE−/− and 11βHSD1−/−/apoE−/− mice fed a Western diet for ∼5 weeks. Foam cell cholesterol levels were reduced 48% in 11βHSD1−/−/apoE−/− mice vs. control. Microarray profiling of peritoneal macrophages revealed differential expression of genes involved in inflammation, stress response and energy metabolism. Several toll-like receptors (TLRs) were downregulated in 11βHSD1−/−/apoE−/− mice including TLR 1, 3 and 4. Cytokine release from 11βHSD1−/−/apoE−/−-derived peritoneal foam cells was attenuated following challenge with oxidized LDL.ConclusionsThese findings suggest that 11βHSD1 inhibition may have the potential to limit plaque development at the vessel wall and regulate foam cell formation independent of changes in plasma lipids. The diminished cytokine response to oxidized LDL stimulation is consistent with the reduction in TLR expression and suggests involvement of 11βHSD1 in modulating binding of pro-atherogenic TLR ligands.

Highlights

  • Glucocorticoids are ubiquitous mammalian hormones involved in the regulation of several fundamental biological processes including energy metabolism, inflammation, arousal, cognition and the response to physiological stress

  • These findings suggest that 11bHSD1 inhibition may have the potential to limit plaque development at the vessel wall and regulate foam cell formation independent of changes in plasma lipids

  • The diminished cytokine response to oxidized LDL stimulation is consistent with the reduction in toll-like receptors (TLRs) expression and suggests involvement of 11bHSD1 in modulating binding of pro-atherogenic TLR ligands

Read more

Summary

Introduction

Glucocorticoids are ubiquitous mammalian hormones involved in the regulation of several fundamental biological processes including energy metabolism, inflammation, arousal, cognition and the response to physiological stress. Cortisol tone is regulated intracellularly by the enzymatic activities of two isoforms of 11b-hydroxysteroid dehydrogenase, type 1 (‘‘11bHSD1’’) and type 2 (‘‘11bHSD2’’). The latter, 11bHSD2, is mainly expressed in aldosterone-target tissues such as kidney, colon and salivary glands [7]. 11bHSD2 converts active cortisol/corticosterone to the inactive form cortisone/11-dehydrocorticosterone, thereby limiting ligand availability for mineralocorticoid receptor binding in these tissues. The enzyme 11b-hydroxysteroid dehydrogenase type 1 (11bHSD1) increases active glucocorticoid levels within tissues by catalyzing the conversion of cortisone to cortisol. The cellular and molecular details for this effect have not been elucidated

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call